📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Antidote

1.1 - Company Overview

Antidote Logo

Antidote

Headquarter: United Kingdom
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of digital health solutions that accelerate and improve medical research by combining proprietary technologies, data, and well-established business models. Offerings include Enterprise Match, a SaaS tool for patient-friendly clinical trial search and matching; Precision Recruitment using data-driven insights; Patient Engagement solutions; and a Partner Network to drive patient engagement and provide research resources.

Products and services

  • Enterprise Match: SaaS-based, patient-friendly clinical trial search that delivers accurate trial discovery on company websites, enabling easy matching and access to consistently up-to-date information
  • Patient Engagement Solutions: Digital campaign–focused services that construct brand–patient connections through strategic planning, audience targeting, and precise campaign execution to find the right patients for clinical trials
  • Precision Recruitment: Data-driven patient identification system that architects targeted recruitment using data-driven insights and digital expertise to find and recruit eligible patients for clinical trials through a strategic approach

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Antidote

Envision Pharma Logo

Envision Pharma

HQ: United States Website
  • Description: Provider of scientific communications and technology solutions for the life science industry, including iEnvision medical affairs and compliance software, medical affairs workflow tools, government pricing & analytics SaaS, strategic consulting for market launch and product acceleration, value & access services, and integrated support for medical communications, publication management, and digital engagement.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Envision Pharma company profile →
Genuity Science Logo

Genuity Science

HQ: United States Website
  • Description: Provider of clinco-omics data analysis solutions and genomic sequence data for researchers, with a platform for study design, sequencing, storage, interpretation, secondary analysis, and scalable analytics. Offers disease-specific clinical omics datasets (CNS, cardiometabolic, inflammatory), powered datasets, deeply phenotyped whole genomes, longitudinal data, and population-scale expertise applying deep learning to improve patient health using the human genome.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Genuity Science company profile →
PHT Logo

PHT

HQ: United States Website
  • Description: Provider of Web-based clinical trial direct data capture and management technologies, including market-leading electronic patient reported outcome (ePRO) solutions used globally in clinical trials. Offers LogPad and StudyPad systems to improve data quality and the StudyWorks online portal providing study sponsors, monitors and sites with real-time access.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full PHT company profile →
Causaly Logo

Causaly

HQ: United Kingdom Website
  • Description: Provider of a biomedical research discovery platform that finds and unlocks hidden evidence in biomedicine to accelerate drug discovery. Offers Causaly Cloud to find, analyze and connect evidence from biomedical documents, a hypothesis generation tool to identify mediators of target-disease effects, and advanced filtering by target class for a granular view of targets for specific diseases.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Causaly company profile →
Proxeon Logo

Proxeon

HQ: Denmark Website
  • Description: Provider of solutions addressing scientific and technical challenges in proteomics, leveraging multidisciplinary expertise across biology, physics, engineering and informatics, developed by scientists actively involved in proteomics research.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Proxeon company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Antidote

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Antidote

2.2 - Growth funds investing in similar companies to Antidote

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Antidote

4.2 - Public trading comparable groups for Antidote

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Antidote

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Antidote

What does Antidote do?

Antidote is a provider of digital health solutions that accelerate and improve medical research by combining proprietary technologies, data, and well-established business models. Offerings include Enterprise Match, a SaaS tool for patient-friendly clinical trial search and matching; Precision Recruitment using data-driven insights; Patient Engagement solutions; and a Partner Network to drive patient engagement and provide research resources.

Who are Antidote's competitors?

Antidote's competitors and similar companies include Envision Pharma, Genuity Science, PHT, Causaly, and Proxeon.

Where is Antidote headquartered?

Antidote is headquartered in United Kingdom.

How many employees does Antidote have?

Antidote has 1,000 employees 🔒.

When was Antidote founded?

Antidote was founded in 2010 🔒.

What sector and industry vertical is Antidote in?

Antidote is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Antidote

Who are the top strategic acquirers in Antidote's sector and industry

Top strategic M&A buyers and acquirers in Antidote's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Antidote?

Top strategic M&A buyers groups and sectors for Antidote include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Antidote's sector and industry vertical

Which are the top PE firms investing in Antidote's sector and industry vertical?

Top PE firms investing in Antidote's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Antidote's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Antidote's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Antidote's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Antidote include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Antidote's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Antidote?

The key public trading comparables and valuation benchmarks for Antidote include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Antidote for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Antidote with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Antidote's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Antidote with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Antidote's' sector and industry vertical?

Access recent funding rounds and capital raises in Antidote's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Antidote